Skip to content

This is a study to compare the efficacy of two ayurvedic medicines (balamula churn and kushabalamula churna) for treatment of Raktapradara (Dysfunctional Uterine Bleeding)

A comparative clinical study to evaluate the efficacy of Balamula Churna and Kusha-Balamula Churna in management of Raktapradara w.s.r. to Dysfunctional Uterine Bleeding. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108480
Enrollment
50
Registered
2026-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

Aakriti Thapliyal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have cardinal and associated features of Raktpradara (DUB). Women having menstruation for more than 5 days. Women having duration of inter menstrual cycle less than 20.

Exclusion criteria

Exclusion criteria: Bleeding from the polyps, erosion, cancer or fibroid. Post menopausal Bleeds. Abortional bleeding in married women. History of the bleeding from the site other than the uterus. Coagulation disorders. Patient infected from HIV, HbsAg, VDRL, HcV, T.B. or having malignancy of affecting part. Ectopic Pregnancy. Severe Anaemia. Patients affected from DUB for more than 5 years.

Design outcomes

Primary

MeasureTime frame
Significant improvement in Raktapradara symptomsTimepoint: Significant improvement in Raktapradara symptoms after 2 Menstrual cycle or after 8 weeks

Secondary

MeasureTime frame
Feeling of well being of the patient and relief in any other associated symptom.Timepoint: Feeling of well being of the patient in three consecutive cycle

Countries

India

Contacts

Public ContactDr Digambar P Shevale

Shri Dhanwantari Ayurvedic Medical College and Research Centre

digs198180@gmail.com9271232369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026